Literature DB >> 28535553

Differences in Pain Processing Between Patients with Chronic Low Back Pain, Recurrent Low Back Pain, and Fibromyalgia.

Dorien Goubert1, Lieven Danneels2, Thomas Graven-Nielsen3, Filip Descheemaeker3, Mira Meeus4.   

Abstract

BACKGROUND: The impairment in musculoskeletal structures in patients with low back pain (LBP) is often disproportionate to their complaint. Therefore, the need arises for exploration of alternative mechanisms contributing to the origin and maintenance of non-specific LBP. The recent focus has been on central nervous system phenomena in LBP and the pathophysiological mechanisms underlying the various symptoms and characteristics of chronic pain. Knowledge concerning changes in pain processing in LBP remains ambiguous, partly due to the diversity in the LBP population.
OBJECTIVE: The purpose of this study is to compare quantitative sensory assessment in different groups of LBP patients with regard to chronicity. Recurrent low back pain (RLBP), mild chronic low back pain (CLBP), and severe CLBP are compared on the one hand with healthy controls (HC), and on the other hand with fibromyalgia (FM) patients, in which abnormal pain processing has previously been reported. STUDY
DESIGN: Cross-sectional study.
SETTING: Department of Rehabilitation Sciences, Ghent University, Belgium.
METHODS: Twenty-three RLBP, 15 mild CLBP, 16 severe CLBP, 26 FM, and 21 HC participated in this study. Quantitative sensory testing was conducted by manual pressure algometry and computer-controlled cuff algometry. A manual algometer was used to evaluate hyperalgesia as well as temporal summation of pain and a cuff algometer was used to evaluate deep tissue hyperalgesia, the efficacy of the conditioned pain modulation and spatial summation of pain.
RESULTS: Pressure pain thresholds by manual algometry were significantly lower in FM compared to HC, RLBP, and severe CLBP. Temporal summation of pain was significantly higher in FM compared to HC and RLBP. Pain tolerance thresholds assessed by cuff algometry were significantly lower in FM compared to HC and RLBP and also in severe CLBP compared to RLBP. No significant differences between groups were found for spatial summation or conditioned pain modulation. LIMITATIONS: No psychosocial issues were taken into account for this study.
CONCLUSION: The present results suggest normal pain sensitivity in RLBP, but future research is needed. In mild and severe CLBP some findings of altered pain processing are evident, although to a lesser extent compared to FM patients. In conclusion, mild and severe CLBP presents within a spectrum, somewhere between completely healthy persons and FM patients, characterized by pain augmentation.

Entities:  

Mesh:

Year:  2017        PMID: 28535553

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  15 in total

1.  Signature for Pain Recovery IN Teens (SPRINT): protocol for a multisite prospective signature study in chronic musculoskeletal pain.

Authors:  Laura Simons; Massieh Moayedi; Robert C Coghill; Jennifer Stinson; Martin S Angst; Nima Aghaeepour; Brice Gaudilliere; Christopher D King; Marina López-Solà; Marie-Eve Hoeppli; Emma Biggs; Ed Ganio; Sara E Williams; Kenneth R Goldschneider; Fiona Campbell; Danielle Ruskin; Elliot J Krane; Suellen Walker; Gillian Rush; Marissa Heirich
Journal:  BMJ Open       Date:  2022-06-08       Impact factor: 3.006

Review 2.  Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives.

Authors:  Carmen M Galvez-Sánchez; Gustavo A Reyes Del Paso
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

3.  Pain inhibition is not affected by exercise-induced pain.

Authors:  Tibor M Szikszay; Waclaw M Adamczyk; Ewa Wojtyna; Kerstin Luedtke
Journal:  Pain Rep       Date:  2020-03-29

4.  Virtual reality distraction induces hypoalgesia in patients with chronic low back pain: a randomized controlled trial.

Authors:  Thomas Matheve; Katleen Bogaerts; Annick Timmermans
Journal:  J Neuroeng Rehabil       Date:  2020-04-22       Impact factor: 4.262

5.  Transcutaneous electrical nerve stimulation and heat to reduce pain in a chronic low back pain population: a randomized controlled clinical trial.

Authors:  Lynn Leemans; Ömer Elma; Jo Nijs; Timothy H Wideman; Carolie Siffain; Hester den Bandt; Sven Van Laere; David Beckwée
Journal:  Braz J Phys Ther       Date:  2020-05-12       Impact factor: 3.377

6.  Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitization.

Authors:  Tine van de Donk; Jurjan van Cosburgh; Tom van Dasselaar; Monique van Velzen; Asbjørn Mohr Drewes; Albert Dahan; Marieke Niesters
Journal:  Pain Rep       Date:  2020-12-17

7.  Pressure pain threshold and temporal summation in adults with episodic and persistent low back pain trajectories: a secondary analysis at baseline and after lumbar manipulation or sham.

Authors:  Sasha L Aspinall; Angela Jacques; Charlotte Leboeuf-Yde; Sarah J Etherington; Bruce F Walker
Journal:  Chiropr Man Therap       Date:  2020-06-12

8.  Relationship between healthcare seeking and pain expansion in patients with nonspecific chronic low back pain.

Authors:  Mónica Grande-Alonso; Daniel Muñoz-García; Ferran Cuenca-Martínez; Laura Delgado-Sanz; María Prieto-Aldana; Roy La Touche; Alfonso Gil-Martínez
Journal:  PeerJ       Date:  2020-03-09       Impact factor: 2.984

9.  Sleep, Experimental Pain and Clinical Pain in Patients with Chronic Musculoskeletal Pain and Healthy Controls.

Authors:  Cindy Stroemel-Scheder; Anna Julia Karmann; Elisabeth Ziegler; Michael Heesen; Katrin Knippenberg-Bigge; Philip M Lang; Stefan Lautenbacher
Journal:  J Pain Res       Date:  2019-12-19       Impact factor: 3.133

10.  Diffuse central sensitization in low back patients: A secondary analysis of cross-sectional data including tender point examination and magnetic resonance imaging of the lumbar spine.

Authors:  Ole Kudsk Jensen; Claus Vinther Nielsen; Kristian Stengaard-Pedersen
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.